by Naz Dana | Sep 26, 2018 | Business |
Since the spring, our blog has featured regular posts introducing Perlara team members who weren’t a part of the founding team. From recent hires to a long-time team member, from two senior scientists to two research associates, we’ve covered almost...
by Ethan Perlstein | Sep 20, 2018 | PMM2-CDG |
Last week, we posted a preprint describing new yeast models of Phosphomannomutase 2 Deficiency, or PMM2-CDG, the most common congenital disorder of glycosylation in the world. This PMM2 model preprint is our second preprint on bioRxiv which, for the uninitiated, is...
by Naz Dana | Aug 23, 2018 | Business |
Last spring, we started a new series of blog posts introducing Perlara team members – from new hires, to not-so-new hires and, in our last post, a long-time Perlara team member. Our goal has been to spotlight the Perlara scientists who may not have started out in the...
by Naz Dana | Jul 23, 2018 | Business |
In the spring, we started introducing the Perlara Team – both new hires as well as not-so-new hires – on the blog. Around the same time, The New York Times launched a now-regular feature – Overlooked – recognizing women whose accomplishments...
by Naz Dana | Jun 26, 2018 | Business |
Last April, we introduced three of Perlara’s newest team members. We will continue to do so as our team grows. In the meantime, we would like to take the time to introduce two of our not-so-new Perlara team members, whom we didn’t have a chance to...
